Discordant Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy Are Associated With Increased Mortality and Poor Adherence to Therapy

Abstract
To examine the independent association of discordant virologic and immunologic responses to highly active antiretroviral therapy (HAART) with mortality. A population-based study of 1527 treatment-naive individuals initiating HAART used Cox proportional hazards modeling to determine the independent association of treatment response at 3 to 9 months with nonaccidental mortality. Logistic regression was used to examine associations with discordant responses. Viral load (VL)+/CD4− discordant responses were seen in 235 (15.4%) of subjects, and VL−/CD4+ responses were seen in 179 (11.7%) of subjects. In adjusted Cox regression models, discordant responses were found to be independently associated with an increased risk of mortality (VL+/CD4−: relative hazard [RH] = 1.87, 95% confidence interval [CI]: 1.15 to 3.04; VL−/CD4+: RH = 2.47, 95% CI: 1.54 to 3.95). VL+/CD4− discordance was found to be associated with increasing age, baseline HIV RNA load 100,000 copies/mL; the use of 3TC/ZDV, didanosine (ddI)/3TC, or ddI/stavudine; and poor adherence to therapy. Discordant responses are independently associated with an increased risk of mortality and are, in turn, associated with poor adherence to therapy.

This publication has 22 references indexed in Scilit: